Morgan Stanley (NYSE:MS) Price Target Increased to $95.00 by Analysts at UBS Group
Morgan Stanley (NYSE:MS – Get Free Report) had its price objective increased by equities researchers at UBS Group from $80.00 to $95.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has a “neutral” rating on the financial services provider’s stock. UBS Group’s price target would suggest a potential upside […]
More Stories
Insider Buying: Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) Director Purchases $181,100.00 in Stock
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) Director Michael R. Hayden purchased 5,000 shares of the company’s stock in...
Insider Buying: Benitec Biopharma Inc. (NASDAQ:BNTC) Director Acquires $301,971.96 in Stock
Benitec Biopharma Inc. (NASDAQ:BNTC – Get Free Report) Director Suvretta Capital Management, L bought 27,502 shares of the business’s stock...
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) CFO Sells $244,842.48 in Stock
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND – Get Free Report) CFO Octavio Espinoza sold 2,104 shares of the stock in a transaction...
Brokerages Set First Citizens BancShares, Inc. (NASDAQ:FCNCA) PT at $2,243.64
First Citizens BancShares, Inc. (NASDAQ:FCNCA – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve...
Matador Resources (NYSE:MTDR) Receives Average Rating of “Moderate Buy” from Brokerages
Shares of Matador Resources (NYSE:MTDR – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the...
R David Schmaier Sells 1,785 Shares of Salesforce, Inc. (NYSE:CRM) Stock
Salesforce, Inc. (NYSE:CRM – Get Free Report) insider R David Schmaier sold 1,785 shares of the business’s stock in a...